123C4

CAS No. 2034159-30-1

123C4( —— )

Catalog No. M29586 CAS No. 2034159-30-1

123C4 is a potent, selective and competitive agonist of the receptor tyrosine kinase EPHA4 (Ki=0.65 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 506 In Stock
5MG 312 In Stock
10MG 511 In Stock
25MG 814 In Stock
50MG 1070 In Stock
100MG 1442 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    123C4
  • Note
    Research use only, not for human use.
  • Brief Description
    123C4 is a potent, selective and competitive agonist of the receptor tyrosine kinase EPHA4 (Ki=0.65 μM).
  • Description
    123C4 is a potent, selective and competitive agonist of the receptor tyrosine kinase EPHA4 (Ki=0.65 μM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Tyrosine Kinase
  • Target
    Ephrin Receptor
  • Recptor
    Ephrin Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2034159-30-1
  • Formula Weight
    807.34
  • Molecular Formula
    C43H47ClN8O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (123.86 mM)
  • SMILES
    COc(cc1)cc2c1[nH]cc2CCNC([C@H](Cc1ccncc1)NC([C@H](Cc(cc1)ccc1Cl)NC([C@H](Cc1c[nH]c(cc2)c1cc2O)NC(CCCN)=O)=O)=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • DY-131

    DY131 is a novel selective agonist of ERRβ and ERRγ.

  • KYL

    EphA4 receptor tyrosine kinase inhibitor (Kd = 0.8 μM); inhibits EphA4-EphrinA5 interactions (IC50 = 6.34 μM). Prevents AβO induced synaptic damage, dendritic spine loss and prevents the blocking of LTP in hippocampal CA3-CA1 transmissions. Exhibits a long half life in cell culture media (8 and 12 hours in PC3 and C2C12 media respectively). Neuroprotective.

  • UniPR505

    UniPR505 is a potent EphA2 antagonist (IC50: 0.95 μM), a novel 3α-carbamoyloxy derivative with antiangiogenic properties.